Ledger.Open graph →
SEC Form D · Amendment · filed March 9, 2022

Apic Bio, Inc

Offering
$8.0M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Stephanie O'Brien, J.D · Cambridge, MADirectorStephen Hoffman · Cambridge, MADirectorJohn Reilly · Cambridge, MAExec · DirectorChristian Mueller · Cambridge, MADirectorDavid Langer · BOLINAS, CADirectorRyan T. Sadlier · Portland, ORExec · DirectorLionheart Venture Fund Management, L.L.C · BOLINAS, CADirectorBrad `. Cowles · Portland, ORDirectorMichael Schafler · New York, NYExec · DirectorDovi Frances · Palo Alto, CADirectorJoshua M. Patinkin · Miami, FLDirectorMichael H. Ash, Md · Pasadena, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗